Frederik Nevens

1990–2025 年に発表

182
論文数
29,399
被引用数
92
h 指数
176
i10 指数

被引用数

Frederik Nevens の年別被引用数1991 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 4 件1996 年: 被引用 4 件1997 年: 被引用 2 件1998 年: 被引用 9 件1999 年: 被引用 22 件2000 年: 被引用 25 件2001 年: 被引用 26 件2002 年: 被引用 29 件2003 年: 被引用 19 件2004 年: 被引用 33 件2005 年: 被引用 46 件2006 年: 被引用 53 件2007 年: 被引用 67 件2008 年: 被引用 95 件2009 年: 被引用 62 件2010 年: 被引用 110 件2011 年: 被引用 120 件2012 年: 被引用 181 件2013 年: 被引用 205 件2014 年: 被引用 207 件2015 年: 被引用 212 件2016 年: 被引用 199 件2017 年: 被引用 309 件2018 年: 被引用 310 件2019 年: 被引用 1,028 件2020 年: 被引用 1,096 件2021 年: 被引用 1,218 件2022 年: 被引用 1,019 件2023 年: 被引用 753 件2024 年: 被引用 1,237 件2025 年: 被引用 584 件2026 年: 被引用 20 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,315 件、この内訳の 18.3%中国: 引用元論文 1,231 件、この内訳の 9.7%イギリス: 引用元論文 900 件、この内訳の 7.1%ドイツ: 引用元論文 847 件、この内訳の 6.7%イタリア: 引用元論文 806 件、この内訳の 6.4%スペイン: 引用元論文 731 件、この内訳の 5.8%フランス: 引用元論文 649 件、この内訳の 5.1%ベルギー: 引用元論文 429 件、この内訳の 3.4%カナダ: 引用元論文 419 件、この内訳の 3.3%オランダ: 引用元論文 404 件、この内訳の 3.2%スイス: 引用元論文 335 件、この内訳の 2.7%日本: 引用元論文 310 件、この内訳の 2.5%
0%18.3%その他 25.8%

分野

  • Medicine80.6%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Pharmacology, Toxicology and Pharmaceutics1.8%
  • Engineering1.6%
  • Immunology and Microbiology1.5%
  • Neuroscience0.5%
  • その他1.9%

トピック

  • Liver Disease Diagnosis and Treatment13.4%
  • Liver Disease and Transplantation9.5%
  • Liver Diseases and Immunity4.5%
  • Organ Transplantation Techniques and Outcomes4.2%
  • Hepatitis C virus research3.1%
  • Hepatocellular Carcinoma Treatment and Prognosis3%
  • その他62.3%

共著者

全論文

検索で開く
  1. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Pruzanski, Д. А. Шапиро - New England Journal of Medicine 2016 被引用: 1,108

  2. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure

    著者: , , , , , , , , , - Journal of Hepatology 2017 被引用: 985

  3. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 被引用: 1,014

  4. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Solé, Germán Soriano, Andrea De Gottardi, Henning Grønbæk, Faouzi Saliba, Christian Trautwein, Osman Özdoğan, Sven Francque, Stephen Ryder, Pierre Nahon, Manuel Romero‐Gómez, Hans Van Vlierberghe, Claire Francoz, Michael P. Manns, Elisabet García, Manuel Tufoni, Àlex Amorós, Marco Pavesi, Cristina Sánchez, Anna Curto, Carla Pitarch, Antonella Putignano, Esau Moreno, Debbie L. Shawcross, Ferrán Aguilar, Joan Clària, Paola Ponzo, Christian Jansen, Zsuzsanna Vitális, Giacomo Zaccherini, Boglárka Balogh, Vı́ctor Vargas, Sara Montagnese, Carlo Alessandria, Mauro Bernardi, Pere Ginès, Rajiv Jalan, Richard Moreau, Paolo Angeli, Vicente Arroyo, Miriam Maschmeier, David Semela, Laure Elkrief, Ahmed M. Elsharkawy, Tamás Tornai, István Tornai, I Altorjay, Agnese Antognoli, Maurizio Baldassarre, Martina Gagliardi, Eleonora Bertoli, Sara Mareso, Alessandra Brocca, Daniela Campion, Giorgio Maria Saracco, Martina Rizzo, Jennifer Lehmann, Alessandra Pohlmann, Michael Praktiknjo, Robert Schierwagen, Elsa Solà, Nesrine Amari, Miguel Rodriguez, Frederik Nevens, Ana Clemente, Peter Jarčuška, Alexander L. Gerbes, Mattias Mandorfer, Christoph Welsch, Emanuela Ciracì ほか 26 名 - Journal of Hepatology 2020 被引用: 504

  5. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2016 被引用: 747

  6. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pietro Invernizzi, Palak Trivedi, Lisa Forman, David E.J. Jones, Stephen Ryder, Mark G. Swain, Alexandra Steinberg, Pol Boudes, Yun‐Jung Choi, Charles A. McWherter, ENHANCE Study Group* - Hepatology 2023 被引用: 113

  7. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Jansen, Christian J. Steib, Daniela Campion, Rajeshwar P. Mookerjee, Miguel Ángel Rodríguez-Gandía, Germán Soriano, François Durand, Daniel Benten, Rafael Bañares, Rudolf Stauber, Henning Grønbæk, Minneke J. Coenraad, Pere Ginès, Alexander L. Gerbes, Rajiv Jalan, Mauro Bernardi, Vicente Arroyo, Paolo Angeli - Journal of Hepatology 2019 被引用: 352

  8. Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding

    著者: , , , , , , , , , , - New England Journal of Medicine 2010 被引用: 1,237

  9. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2014 被引用: 489

  10. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Presa Ramos, Cristina Solé, Germán Soriano, Andrea De Gottardi, Henning Grønbæk, Faouzi Saliba, Christian Trautwein, Haluk Tarık Kani, Sven Francque, Stephen Ryder, Pierre Nahon, Manuel Romero‐Gómez, Hans Van Vlierberghe, Claire Francoz, Michael P. Manns, Elisabet García, Manuel Tufoni, Àlex Amorós, Marco Pavesi, Cristina Sánchez, Michael Praktiknjo, Anna Curto, Carla Pitarch, Antonella Putignano, Esau Moreno, William Bernal, Ferrán Aguilar, Joan Clària, Paola Ponzo, Zsuzsanna Vitális, Giacomo Zaccherini, Boglárka Balogh, Alexander L. Gerbes, Vı́ctor Vargas, Carlo Alessandria, Mauro Bernardi, Pere Ginès, Richard Moreau, Paolo Angeli, Rajiv Jalan, Vicente Arroyo, Miriam Maschmeier, David Semela, Laure Elkrief, Ahmed M. Elsharkawy, Tamás Tornai, István Tornai, I Altorjay, Agnese Antognoli, Maurizio Baldassarre, Martina Gagliardi, Eleonora Bertoli, Sara Mareso, Alessandra Brocca, Daniela Campion, Giorgio Maria Saracco, Martina Rizzo, Jennifer Lehmann, Alessandra Pohlmann, Maximilian Joseph Brol, Johannes Chang, Robert Schierwagen, Elsa Solà, Nesrine Amari, Miguel Ángel Morán Rodríguez, Frederik Nevens, Ana Clemente, Martin Janíčko, Daniel Markwardt, Mattias Mandorfer ほか 29 名 - Journal of Hepatology 2020 被引用: 288

  11. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 被引用: 436

  12. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

    著者: , , , , , , , , , , , , , - Scientific Reports 2016 被引用: 229

  13. Acute-on-chronic liver failure in cirrhosis

    著者: , , , , , , , , , - Nature Reviews Disease Primers 2016 被引用: 431

  14. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2017 被引用: 287

  15. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 被引用: 277

  16. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook ほか 56 名 - Gastroenterology 2022 被引用: 101

  17. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 被引用: 321

  18. The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats

    著者: , , , , , , , , , , , , , , - American Journal Of Pathology 2015 被引用: 209

  19. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vilas Patwardhan, Cristina Rigamonti, Marco Carbone, Pietro Invernizzi, Laura Cristoferi, Adriaan van der Meer, Rozanne de Veer, Ehud Zigmond, Eyal Yehezkel, Andreas E. Kremer, Ansgar Deibel, Jérôme Dumortier, Tony Bruns, Karsten Große, Georges‐Philippe Pageaux, Aaron Wetten, Jessica Dyson, David G. Jones, Olivier Chazouillères, Bettina Hansen, Victor de Lédinghen - Journal of Hepatology 2022 被引用: 116

  20. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen D. Shafran, Jin Hou, Jan Šperl, Petr Urbánek, Stanislav Plíšek, Václav Hejda, Didier Samuel, Karine Lacombe, Fabien Zoulim, Dominique Guyader, F. Raffi, Tarik Asselah, Marc Bourlière, Marie‐Noëlle Hilleret, Heiner Wedemeyer, Julian Schulze zur Wiesch, Kathrin Sprinzl, Kathrin Sprinzl, Gudrun Hilgard, Michael Sabranski, Keikawus Arastéh, Henry LY Chan, Man‐Fung Yuen, Vincent Wai‐Sun Wong, Maurizia Rossana Brunetto, Gloria Taliani, Pietro Andreoné, Pietro Lampertico, Masayuki Kurosaki, Hiroshi Yatsuhashi, Kei Fujiwara, Tetsuo Takehara, Tomokazu Kawaoka, Yasuhiro Asahina, Hirayuki Enomoto, Kazuhisa Yabushita, Kazuo Notsumata, Koichi Takaguchi, Naoto Kawabe, Naoya Kato, Naoto Kawabe, Tadashi Namisaki, Yoshiyuki Suzuki, Jung‐Hwan Yoon, Sang Hoon Ahn, Young‐Suk Lim, Seung Woon Paik, Kuang Kiat Kiew, Rosmawati Mohamed, Soek Siam Tan, Yeong Yeh Lee, Maria Hlebowicz, Hanna Berak, Jacek Gąsiorowski, Waldemar Halota, Ewa Janczewska, Natalia Geyvandova, Viacheslav Morozov, А. А. Андреева, Д. А. Гусев, E. I. Bessonova, М. Ф. Осипенко, Svetlana Romanova, Natalia Gankina, Olga Sagalova, Tatiana Stepanova, Olga Sagalova, M. Diago, Fernandez Inmaculada, José Luís Calleja ほか 24 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 76

  21. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 171

  22. Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial

    著者: , , , , , , , - Liver International 2023 被引用: 65

  23. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function

    著者: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2013 被引用: 175

  24. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2012 被引用: 561